Skip to content

Xtant Medical Holdings XTNT Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
Medtronic logo
MedtronicMDT
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
MiMedx Group logo
MiMedx GroupMDXG

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
Enterprise value$61.89M-41.5%
P/E32.3×
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's common stock, shares, outstanding?
Xtant Medical Holdings (XTNT) reported common stock, shares, outstanding of $140.07M in Q1 2026.
How has Xtant Medical Holdings's common stock, shares, outstanding changed year-over-year?
Xtant Medical Holdings's common stock, shares, outstanding increased by 0.7% year-over-year, from $139.08M to $140.07M.
What is the long-term trend for Xtant Medical Holdings's common stock, shares, outstanding?
Over 5 years (2020 to 2025), Xtant Medical Holdings's common stock, shares, outstanding has grown at a 12.5% compound annual growth rate (CAGR), from $77.57M to $140.04M.